Joseph P. ST. LAURENT,Gerald S. JONES,David M. BRESSE,Scott A. GOODRICH
申请号：
US15046707
公开号：
US20160158252A1
申请日:
2016.02.18
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and diethyl (2-cyanoethyl)phosphonate, or a pharmaceutically acceptable salt thereof. The present invention is directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering diethyl (2-cyanoethyl)phosphonate, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. The present invention is also directed to a method of treating an inflammatory skin disease or disorder, such as dermatitis, psoriasis, acne, or rosacea, by administering to the subject (2-cyanoethyl)phosphonate, or a pharmaceutically acceptable salt or solvate thereof, in an amount effective to reduce or eliminate the symptoms of the inflammatory skin disease or disorder. Topical administration and oral administration are preferred route of administration.
